Real World Experience of a Single-Center Tumor Infiltrating Lymphocyte (TIL) Melanoma Therapy Program: primary referral to TIL infusion (Brain to Vein)
Year: 2025
Type: article
Study design: Observational Study
Source: Cytotherapy
Authors: A. Desai, C. Valenzuela, B. Hayes-Lattin, M. Blackburn, A. Kohn, R. Bixler, B. Ratterree, S. Williamson, R. Knight, G. Meyers, J. Vetto, R. Maziarz
Institution: Oregon Health & Science University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409909536